Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

@article{Liu2016OuterMV,
  title={Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.},
  author={Qiong Liu and Qing Liu and Jie Yi and Kang Liang and Tian Liu and Kenneth L Roland and Yan-Long Jiang and Qingke Kong},
  journal={International journal of medical microbiology : IJMM},
  year={2016},
  volume={306 8},
  pages={
          697-706
        }
}

Figures and Tables from this paper

Immunization With Outer Membrane Vesicles Derived From Major Outer Membrane Protein-Deficient Salmonella Typhimurium Mutants for Cross Protection Against Salmonella Enteritidis and Avian Pathogenic Escherichia coli O78 Infection in Chickens
TLDR
Evaluating the potential of broad-spectrum vaccines based on major outer membrane protein (OMP)-deficient OMVs, including ΔompA, ΔompC, and ΔompD, and the protection effectiveness of these candidate vaccines in murine and chicken infection models confirmed the feasibility of improving the immunogenicity of OMVs by remodeling the outer membrane.
Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC)
TLDR
The animal experiment has confirmed that immunization with an appropriate dose of MOMVs could not cause any adverse effect and was able to reduce bacteria loads and pro-inflammatory cytokines production, thus providing effective cross-protection against lethal infections induced by multi-serogroup APEC strains in chickens.
Outer Membrane Vesicles Derived from Salmonella enterica Serotype Typhimurium Can Deliver Shigella flexneri 2a O-Polysaccharide Antigen To Prevent Shigella flexneri 2a Infection in Mice
TLDR
The present study provides a new strategy for vaccine design, combining a glycoconjugated vaccine with OMVs, and believes that the novel vaccine design strategy in which polysaccharide antigens are delivered via bacterial OMVs will be effective for the development and clinical application of an effective Shigella vaccine.
An OMV-Based Nanovaccine Confers Safety and Protection against Pathogenic Escherichia coli via Both Humoral and Predominantly Th1 Immune Responses in Poultry
TLDR
The data revealed the involvement of both non-specific immune responses and specific antibody and cytokine responses in the APEC_OMV-mediated protection, providing broader knowledge for the development of multivalent APEC O2-derived OMVs-based nanovaccine with high safety and efficacy in the future.
Detection of virulence genes and investigation of the immunogenicity of outer membrane proteins of Salmonella enterica
TLDR
The results of the protection studies indicated that the selected OMPs conferred varying degrees of protection, however, the highest protection was observed using the 38-kDa OMP, which provided 100% protection to mice challenged with 50× LD50 of S. Typhimurium SA3 and 75%protection to mice subjected to an even higher bacterial challenge of 100×LD50.
An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral Salmonella Infection
TLDR
It is shown that opsonizing anti-Salmonella antibodies are induced in response to immunization and that CD4 T cells and B cells can be induced when OMVs are used as the oral adjuvant of a Salmonella-specific vaccine adjuvanted with Burkholderia pseudomallei outer membrane vesicles.
“One for All”: Functional Transfer of OMV-Mediated Polymyxin B Resistance From Salmonella enterica sv. Typhi ΔtolR and ΔdegS to Susceptible Bacteria
TLDR
This work shows that mutants in genes related to OMVs biogenesis can release vesicles with improved abilities to protect bacteria against membrane-active agents, which might be considered the source for the emergence of polymyxin resistance in an entire bacterial community.
...
...

References

SHOWING 1-10 OF 67 REFERENCES
Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice
TLDR
The results indicated that the mutant ∆waaC12 can elicit higher cross-reactivity and can provide good protection against S. Choleraesuis and S. Enteritidis infection and that the cross- reactivity may be ascribed to an antigen of approximately 18.4–30 kDa.
Immunization with Salmonella enterica Serovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge with Streptococcus pneumoniae
TLDR
It is established that vesicles can be used to mucosally deliver an antigen from a Gram-positive organism and induce a protective immune response.
Outer Membrane Vesicles Induce Immune Responses to Virulence Proteins and Protect against Colonization by Enterotoxigenic Escherichia coli
TLDR
It is demonstrated that immunization with OMV impairs ETEC colonization of the small intestine and stimulates antibodies that recognize the heat-labile toxin and two additional putative virulence proteins, the EtpA adhesin and CexE, which suggest that OMV could be exploited to deliver protective antigens relevant to development of ETEC vaccines.
Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi
TLDR
Results indicate the usefulness of OMPs in the induction of active immunity against S. typhi in mice and indicate the ability of lipopolysaccharide to induce protection against challenge with the bacteria in mucin.
Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice
TLDR
Outer membrane proteins (OMP) extracted from both smooth and rough strains of Salmonella typhimurium were able to induce protective immunity to salmonellosis, and delayed-type hypersensitivity appeared as early as the second week after immunization with OMP and persisted through the fourth week.
Effect of Deletion of Genes Involved in Lipopolysaccharide Core and O-Antigen Synthesis on Virulence and Immunogenicity of Salmonella enterica Serovar Typhimurium
TLDR
The results indicate that nonreversible truncation of the outer core is not a viable option for developing a live oral Salmonella vaccine, while a wzy mutant that retains one O-antigen unit is adequate for stimulating the optimal protective immunity to homologous or heterologous antigens by oral, intranasal, or intraperitoneal routes of administration.
Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella enterica Serovar Typhimurium msbB Mutant
TLDR
LPS derived from msbB mutants induced less inflammatory responses in human Mono Mac 6 and murine macrophage RAW2647 cells in vitro and led to higher IgA production in the vaginal tract but still retained the same IgG titer level in serum to PspA, a test antigen from Streptococcus pneumoniae, and to outer membrane proteins from Salmonella.
Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice.
TLDR
It is exhibited for the first time that oral immunization of adult female mice with purified OMVs of Shigella, without any adjuvant, conferred passive protection to their offspring against shigellosis.
Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella
TLDR
The ability of anti-flagellar antibodies to mediate microbial killing by immune system components in-vitro is examined and their role in protecting mice against invasive Salmonella infection is confirmed, establishing that immune responses toSalmonella surface antigens can be protective.
Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
TLDR
It is shown here that oral immunization with purified outer membrane vesicles (OMVs) of Vibrio cholerae induces a prolonged high rise in the protective antibody titre, and OMVs were found to be significantly less reactogenic than the live and the heat-killed bacteria.
...
...